Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Schouw & Co. share buy-back programme, week 46 2025
-
VanEck Debuts Solana ETF: VSOL Launches with Zero Fees
-
Avolon selects CFM LEAP engines to power new A320neo fleet
-
GEP Recognized in the 2025 Gartner ® Magic Quadrant ™ for Contract Lifecycle Management (CLM)
-
Artists & Robots Launches; Returns Human Creative to an AI-Fueled World
-
Cardano Summit 2025 Concludes In Berlin: Trust Emerges As The Winner with Traditional Financial Firms Feeling Blockchain FOMO
-
5 Top 100x Crypto Tokens Set to Soar in 2025 – One’s Shattering Records
-
Molina Healthcare Announces Proposed Offering of $750 Million of Senior Notes Due 2031
-
LBank Exchange Will List TITANIUM (TIT)
-
TearOptix Secures Strategic Funding to Transform Presbyopia Treatment and Announces Creation of Scientific Advisory Board
-
Winthrop Wealth Named to Inc.'s 2025 Best Workplaces List
-
Honda Powers the Dreams of Team USA Athletes as They Go for Gold in Milano Cortina
-
Anixa Biosciences Announces World Health Organization (WHO) Approval of International Non-Proprietary Name for its CAR-T Therapy, Marking a Key Milestone Toward Global Recognition and Future Commercia
-
Halda Therapeutics Announces Acquisition by Johnson & Johnson
-
Onto Innovation Completes Acquisition of Unique Materials Composition and Electrical Analysis Product Lines from Semilab International
-
Rockhaven Reports Multiple High-Grade Vein Exposures at its Klaza Gold-Silver Project, Yukon
-
VITAS® Healthcare Expands Hospice Care in Florida, Now Serving Pinellas County
-
Accenture Invests in Alembic to Reinvent Marketing Measurement with Data and Causal AI
-
Boston Omaha Corporation Announces Adoption of $30 Million Class A Common Stock Repurchase Program
-
ProVen Growth and Income VCT plc: Publication of Prospectus
-
Synack Introduces New Agentic AI Pentesting Solution
-
Inspire Advisors Named to Newsweek's Top Financial Advisory Firms 2026
-
MedStar Washington Hospital Center Surpasses 500th HeartMate 3 LVAD Implant, Leading the Nation in Cardiac Innovation
-
MUSASHI JAPAN by TAIMATSU Launches “Dual Blades” – A Black Friday Experience Redefining Luxury Craftsmanship
-
ProVen VCT plc: Publication of Prospectus
-
Scope Technologies Corp. Achieves CyberSecure Canada Level 2 Certification, Advancing Its Leadership in Quantum-Resilient Security and Compliance
-
Cytokinetics Supports American Heart Association Initiative to Improve Care for People Living With Hypertrophic Cardiomyopathy
-
Datavault AI Reports 3Q-25 Highlights and Corporate Update
-
Aeries Technology featured in Everest Group's PEAK Matrix for GCC Setup Capabilities 2025 for the Second Year Running
-
CoinLander Surpasses $600K TVL in 23 Days, Signaling Strong Demand for Tokenized Real Estate Debt
-
Four Points Technology Achieves CMMC 2.0 Level 2 Certification
-
VCI Global Declares Special Dividend of V Gallant Shares as Cybersecurity & AI Subsidiary Prepares for Nine-Figure Nasdaq IPO
-
Eshallgo Inc. Highlights Strong Momentum Across Global Shares; Highlights on Recent Operational Developments and Strategic U.S. Expansion
-
Jeffs’ Brands: Jeffs’ Brands Holdings Enters Into a Non-Binding MOU for an Exclusive Multi Continent Distribution Agreement of an Electromagnetic Imaging, AI Homeland Security Technology
-
VCI Global Declares Special Dividend of V Gallant Shares as Cybersecurity & AI Subsidiary Prepares for Nine-Figure Nasdaq IPO
-
Artificial intelligence, authentic risk: AI-powered threats to soar, warn anti-fraud professionals
-
Ensysce Biosciences Secures $4 Million Financing, Unlocking Up to $20 Million in Total Financing to Advance Breakthrough Pain Programs
-
imagine.io Launches VisualScale.ai on Google Cloud Marketplace to Deliver Brand-True, AI-Generated Product Visuals at Scale
-
Rigel Announces Publication of Final 5-year Data on REZLIDHIA® (olutasidenib) in Patients with R/R mIDH1 AML in the Journal of Hematology & Oncology
-
Iron Cap Group Introduces Next-Generation Market Access Engine for Rapid Activation
-
PRA Group to Participate in Upcoming Investor Events
-
Biotheryx Announces Completion of Enrollment in Phase 1a Clinical Trial of BTX-9341 for the Treatment HR+/HER2- Breast Cancer
-
New long-term data reinforces TREMFYA® (guselkumab) as the only IL-23 inhibitor proven to substantially inhibit structural joint damage in active psoriatic arthritis
-
Alembic Raises $145 Million to Accelerate Enterprise Adoption of Causal AI
-
Sonoma Biotherapeutics Announces Transition of Jeff Bluestone, PhD, to Advisor; Appoints Stephen Dilly, MBBS, PhD, as President and Chief Executive Officer
-
Airsys Unveils PowerOne™ AI-Era Cooling Solutions for Modern Data Centers
-
Butterfly Network Launches Compass AI to Power the Next Generation of POCUS Program Management
-
Financial Advisor Shawna Vanaken Moves from Commonwealth to Cetera's Avantax Community of Tax-Focused Financial Professionals
-
Silo Pharma Partners with Allucent to Support Planned FDA Investigational New Drug Application for SPC-15 as a Therapeutic for PTSD
-
Ashvattha Therapeutics to Showcase Topline Phase 2 Data and Recent FDA Alignment at Upcoming Investor and Ophthalmology Meetings
